By expenditures
| Name | Title | Type |
|---|---|---|
| Marsha Bohannon | Treasurer | Auditee |
| Kevin Kerswick | Partner | Auditee |
| Brian Tomamichel | CHIEF FINANCIAL OFFICER | Auditee |
| Vanessa Rossitto | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 329409 | 2024 | 2024-11-22 | Crowe LLP | $12.75M |
| 16268 | 2022 | 2023-03-30 | Cliftonlarsonallen LLP | $9.56M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 329409 | 2024 | 2024-11-22 | 1086198 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 1086197 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 1086196 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 1086195 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 1086194 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 1086193 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 1086192 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 1086191 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 1086190 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 1086189 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 1086188 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 1086187 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 1086186 | 2024-001 | Material Weakness | - | E |
| 329409 | 2024 | 2024-11-22 | 1086185 | 2024-001 | Material Weakness | - | E |
| 329409 | 2024 | 2024-11-22 | 1086184 | 2024-001 | Material Weakness | - | E |
| 329409 | 2024 | 2024-11-22 | 1086183 | 2024-001 | Material Weakness | - | E |
| 329409 | 2024 | 2024-11-22 | 509756 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 509755 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 509754 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 509753 | 2024-004 | Significant Deficiency | - | N |
| 329409 | 2024 | 2024-11-22 | 509752 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 509751 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 509750 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 509749 | 2024-003 | Material Weakness | - | I |
| 329409 | 2024 | 2024-11-22 | 509748 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 509747 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 509746 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 509745 | 2024-002 | Material Weakness | - | L |
| 329409 | 2024 | 2024-11-22 | 509744 | 2024-001 | Material Weakness | - | E |
| 329409 | 2024 | 2024-11-22 | 509743 | 2024-001 | Material Weakness | - | E |
| 329409 | 2024 | 2024-11-22 | 509742 | 2024-001 | Material Weakness | - | E |
| 329409 | 2024 | 2024-11-22 | 509741 | 2024-001 | Material Weakness | - | E |
| 16268 | 2022 | 2023-03-30 | 588607 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 588606 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 588605 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 588604 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 588603 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 588602 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 588601 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 12165 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 12164 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 12163 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 12162 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 12161 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 12160 | 2022-001 | Significant Deficiency | Yes | I |
| 16268 | 2022 | 2023-03-30 | 12159 | 2022-001 | Significant Deficiency | Yes | I |